VTechWorks staff will be away for the Thanksgiving holiday beginning at noon on Wednesday, November 27, through Friday, November 29. We will resume normal operations on Monday, December 2. Thank you for your patience.
 

Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infection

Simple item page
dc.contributor.authorMohamed, Mohamed F.en
dc.contributor.authorSeleem, Mohamed N.en
dc.date.accessioned2020-09-21T16:16:38Zen
dc.date.available2020-09-21T16:16:38Zen
dc.date.issued2014-01-01en
dc.date.updated2020-09-21T16:16:36Zen
dc.description.abstractThe therapeutic efficacy of two novel short antimicrobial and anti-inflammatory peptides (RR and RRIKA) was evaluated in a mouse model of staphylococcal skin infection. RR (2%) and RRIKA (2%) significantly reduced the bacterial counts and the levels of proinflammatory cytokines, tumor necrosis factor (TNF)-α, and interleukin (IL)-6, in methicillin-resistant Staphylococcus aureus USA 300-0114 skin lesions. Furthermore, the combined therapy of RRIKA (1%) and lysostaphin (0.5%) had significantly higher antistaphylococcal and anti-inflammatory activity compared to monotherapy. This study supports the potential use of these peptides for topical treatment of methicillin-resistant Staphylococcus aureus skin infections.en
dc.description.versionPublished versionen
dc.format.extentPages 1979-1983en
dc.format.extent5 page(s)en
dc.format.mediumElectronic-eCollectionen
dc.format.mimetypeapplication/pdfen
dc.identifier.doihttps://doi.org/10.2147/DDDT.S72129en
dc.identifier.eissn1177-8881en
dc.identifier.issn1177-8881en
dc.identifier.orcidSeleem, Mohamed [0000-0003-0939-0458]en
dc.identifier.otherdddt-8-1979 (PII)en
dc.identifier.pmid25378910 (pubmed)en
dc.identifier.urihttp://hdl.handle.net/10919/100039en
dc.identifier.volume8en
dc.language.isoenen
dc.publisherDove Medical Pressen
dc.rightsCreative Commons Attribution-NonCommercial 3.0 Unporteden
dc.rights.urihttp://creativecommons.org/licenses/by-nc/3.0/en
dc.subjectLife Sciences & Biomedicineen
dc.subjectChemistry, Medicinalen
dc.subjectPharmacology & Pharmacyen
dc.subjectantimicrobial peptidesen
dc.subjectMRSAen
dc.subjectlysostaphinen
dc.subjectskin infectionen
dc.subjectmiceen
dc.subjectIN-VIVOen
dc.subjectLYSOSTAPHINen
dc.subjectINFLAMMATIONen
dc.subjectWOUNDSen
dc.subjectALPHAen
dc.subjectMRSAen
dc.subject1115 Pharmacology and Pharmaceutical Sciencesen
dc.subject.meshAnimalsen
dc.subject.meshMice, Inbred BALB Cen
dc.subject.meshMiceen
dc.subject.meshStaphylococcal Skin Infectionsen
dc.subject.meshDisease Models, Animalen
dc.subject.meshAntimicrobial Cationic Peptidesen
dc.subject.meshAnti-Inflammatory Agents, Non-Steroidalen
dc.subject.meshMicrobial Sensitivity Testsen
dc.subject.meshFemaleen
dc.subject.meshMethicillin-Resistant Staphylococcus aureusen
dc.titleEfficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcus aureus (MRSA) skin infectionen
dc.title.serialDrug Design Development and Therapyen
dc.typeArticle - Refereeden
dc.type.dcmitypeTexten
dc.type.otherArticleen
dc.type.otherJournalen
pubs.organisational-group/Virginia Tech/Veterinary Medicineen
pubs.organisational-group/Virginia Tech/Faculty of Health Sciencesen
pubs.organisational-group/Virginia Tech/All T&R Facultyen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/Biomedical Sciences and Pathobiologyen
pubs.organisational-group/Virginia Tech/Veterinary Medicine/CVM T&R Facultyen
pubs.organisational-group/Virginia Techen

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Efficacy of short novel antimicrobial and anti-inflammatory peptides in a mouse model of methicillin-resistant Staphylococcu.pdf
Size:
590.49 KB
Format:
Adobe Portable Document Format
Download

Collections

All Faculty Deposits
Scholarly Works, Biomedical Sciences and Pathobiology